NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lingang Blue Bay Capital

Lingang Blue Bay Capital

—lingangbluebaycapital.vdtrxn

Overview

-

Portfolio Companies

6

Investments

Lingang Blue Bay Capital investments
CompanyDateStageLead
Sanegene BioDec 2023Series A ExtensionCo-investor
LifeShield MedicalOct 2023Series BCo-investor
Kactus BiosystemsOct 2022Series BCo-investor
Zencore BiologicsAug 2022Series C ExtensionCo-investor
Shanghai Desano Pharmaceutical Group Co., Ltd.Mar 2022Series A ExtensionCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters—
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.